Skip to main content
Signal8

Joshi Manher

SEC insider (Form 3/4/5 filer). CIK 0001978048. Chief Medical Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Aug 17, 2026. Located in BOSTON, MA.

Companies Joshi Manher has filed insider reports for

  • RHYTHM PHARMACEUTICALS, INC. (RYTM): Officer, Chief Medical Officer
  • SOLENO THERAPEUTICS INC (SLNO): Officer, Chief Development Officer
Joshi Manher profile photo

Joshi Manher

CIK: 0001978048

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)1 (16.7%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

RHYTHM PHARMACEUTICALS, INC. logo
RYTM

RHYTHM PHARMACEUTICALS, INC.

Officer
SOLENO THERAPEUTICS INC logo
SLNO

SOLENO THERAPEUTICS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

  • RHYTHM PHARMACEUTICALS, INC. logo
    RYTM

    RHYTHM PHARMACEUTICALS, INC.

    Aug 17, 2026
    Award

    Stock Options (Right to Buy)

    Direct
    50K shares-
  • RHYTHM PHARMACEUTICALS, INC. logo
    RYTM

    RHYTHM PHARMACEUTICALS, INC.

    Aug 17, 2026
    Award

    Restricted Stock Units

    Direct
    25K shares-
  • SOLENO THERAPEUTICS INC logo
    SLNO

    SOLENO THERAPEUTICS INC

    May 18, 2026
    Disposition
    Direct
    20.2K shares-
  • SOLENO THERAPEUTICS INC logo
    SLNO

    SOLENO THERAPEUTICS INC

    Jan 21, 2026
    Award
    Direct
    4.1K shares-
  • SOLENO THERAPEUTICS INC logo
    SLNO

    SOLENO THERAPEUTICS INC

    Nov 10, 2025
    Award
    Direct
    16.1K shares-
  • SOLENO THERAPEUTICS INC logo
    SLNO

    SOLENO THERAPEUTICS INC

    Nov 10, 2025
    Exercise

    Employee stock option (right to buy)

    Direct
    72.3K shares-

1-6 of 6